Daniel possesses extensive experience in representing companies in a wide range of international commercial transactions, with an emphasis on mergers and acquisitions, financing transactions and sophisticated technology transfer arrangements.
Daniel provides counsel on a variety of commercial fields, including technology licensing transactions, domestic and international R&D grants, distribution and manufacturing agreements, capital raising, complex joint ventures, sale of assets and privacy protection.
In addition, Daniel manages the firm’s activities in the field of options and employee equity incentives. In this framework, Daniel counsels startups, technology companies, and senior managers on all aspects of designing and implementing capital incentive plans and individual grants for employees and senior executives.
Daniel’s clients include venture capital funds, investors, industrial companies, and startups in various fields – medical devices, augmented and virtual reality, internet, fintech etc.
The Interdisciplinary Center Herzliya (LL.B, B.A Business Administration), 2009
Member of Israel Bar Association since 2010
News and updates - Daniel Lorber:
Barnea Represented Axcel in the Acquisition of Phase One
Our firm represented Axcel in the acquisition of Phase One from Silverfleet Capital. Axcel is a leading Nordic private equity firm focusing on mid-market companies. It has a broad base of both Nordic and international investors.
Hosting a Delegation of German Medical Companies
Our firm hosted a delegation of German Companies, part of the Tech7 collaboration with SCE in the BIPA program (Bavarian Israeli Partnership Accelerator).
Barnea Represented VVNP in Investment Round in Aleph Farms
Our firm represented the Singapore-based venture capital fund VisVires New Protein (VVNP) in an investment round in Aleph Farms, an Israeli food-tech startup.